Eric Warren - Net Worth and Insider Trading
Eric Warren Net Worth
The estimated net worth of Eric Warren is at least $2 Million dollars as of 2026-08-04. Eric Warren is the Chief Commercial Officer of Esperion Therapeutics Inc and owns about 370,218 shares of Esperion Therapeutics Inc (ESPR) stock worth over $1 Million. Eric Warren is also the Chief Commercial Officer of Mineralys Therapeutics Inc and owns about 38,400 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $1 Million. Details can be seen in Eric Warren's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Warren has not made any transactions after 2026-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Warren
Eric Warren Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Warren owns 2 companies in total, including Esperion Therapeutics Inc (ESPR) , and Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of Eric Warren’s form 4 insider trades.
Insider Ownership Summary of Eric Warren
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2025-04-17 | Chief Commercial Officer |
| MLYS | Mineralys Therapeutics Inc | 2026-07-21 | Chief Commercial Officer |
Eric Warren Latest Holdings Summary
Eric Warren currently owns a total of 2 stocks. Among these stocks, Eric Warren owns 370,218 shares of Esperion Therapeutics Inc (ESPR) as of April 17, 2025, with a value of $1 Million and a weighting of 53.77%. Eric Warren also owns 38,400 shares of Mineralys Therapeutics Inc (MLYS) as of July 21, 2026, with a value of $1 Million and a weighting of 46.23%.
Latest Holdings of Eric Warren
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2025-04-17 | 370,218 | 3.18 | 1,177,293 |
| MLYS | Mineralys Therapeutics Inc | 2026-07-21 | 38,400 | 26.36 | 1,012,224 |
Holding Weightings of Eric Warren
Eric Warren Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Warren has made a total of 27 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 1 buys and 26 sells. The most-recent trade in Esperion Therapeutics Inc is the sale of 108 shares on April 17, 2025, which brought Eric Warren around $106.
According to the SEC Form 4 filings, Eric Warren has made a total of 2 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 7,438 shares on July 21, 2026, which brought Eric Warren around $199,859.
Insider Trading History of Eric Warren
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Eric Warren Trading Performance
GuruFocus tracks the stock performance after each of Eric Warren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Warren is -6.97%. GuruFocus also compares Eric Warren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Warren within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Warren's insider trading performs compared to the benchmark.
Performance of Eric Warren
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.19 | | | | | |
| Relative Return to S&P 500(%) | -0.85 | | | | | |
Eric Warren Ownership Network
Ownership Network List of Eric Warren
Ownership Network Relation of Eric Warren
Eric Warren Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Eric Warren is the Chief Commercial Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Operating Officer Sheldon L. Koenig , and General Counsel Benjamin Looker .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Eric Warren made 3 insider transaction in Esperion Therapeutics Inc (ESPR) with a net sale of 2,780. Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 42,374 shares made by Benjamin Halladay , a net sale of 40,979 shares made by Benjamin Looker , and a net sale of 199,358 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 76,185 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 76,185 shares. During the past 18 months, 285,491 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 285,491 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Eric Warren Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Warren. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Warren's mailing address is: Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
